scPharmaceuticals
Stock Forecast, Prediction & Price Target
scPharmaceuticals (SCPH) stock Price Target by analysts
$13
Potential upside: 191.47%
scPharmaceuticals price prediction
What is scPharmaceuticals stock analysts` prediction?
scPharmaceuticals stock forecast: Based on 1 Wall Street analysts` predicted price targets for scPharmaceuticals in the last 3 months, the avarage price target is $13, with a high forecast of $NaN. The average price target represents a 191.47% change from the last price of $4.46.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
scPharmaceuticals stock Price Target by analysts
Full breakdown of analysts given scPharmaceuticals price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Glen Santangelo Jefferies | 0% 0/1 | 9 months ago | $13 191.47% upside | $3.81 | StreetInsider | Previous targets (0) |
scPharmaceuticals Financial Estimates
scPharmaceuticals Revenue Estimates
scPharmaceuticals EBITDA Estimates
scPharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $13.59M 0% | Avg: $95.72M Low: $74.76M High: $119.76M avg. 604.24% | Avg: $182.56M Low: $153.22M High: $223.65M avg. 90.71% | Avg: $286.25M Low: $240.25M High: $350.69M avg. 56.79% | Avg: $327.81M Low: $275.13M High: $401.61M avg. 14.52% |
Net Income
% change YoY
| $-30.48M N/A | $-37.51M -23.06% | $-54.81M -46.08% | Avg: $-30.61M Low: $-42.75M High: $-17.33M avg. 44.14% | Avg: $35.55M Low: $-1.54M High: $56.61M avg. 216.13% | Avg: $91.47M Low: $72.36M High: $118.23M avg. 157.29% | Avg: $139.29M Low: $110.19M High: $180.05M avg. 52.28% |
EBITDA
% change YoY
| $-25.45M N/A | $-33.53M -31.72% | $-46.06M -37.34% | Avg: $57.43M Low: $44.85M High: $71.85M avg. 224.69% | Avg: $109.53M Low: $91.93M High: $134.19M avg. 90.71% | Avg: $171.75M Low: $144.15M High: $210.41M avg. 56.79% | Avg: $196.69M Low: $165.08M High: $240.96M avg. 14.52% |
EPS
% change YoY
| -$1.11 N/A | -$1.32 -18.91% | -$1.42 -7.57% | Avg: -$0.73 Low: -$1.11 High: -$0.45 avg. 48.35% | Avg: $0.84 Low: -$0.04 High: $1.47 avg. 214.00% | Avg: $2.38 Low: $1.88 High: $3.07 avg. 184.09% | Avg: $3.62 Low: $2.86 High: $4.68 avg. 52.28% |
Operating Expenses
% change YoY
| $25.82M N/A | $36.15M 40.01% | $65.17M 80.26% | Avg: $151.75M Low: $118.51M High: $189.85M avg. 132.82% | Avg: $289.40M Low: $242.89M High: $354.55M avg. 90.71% | Avg: $453.78M Low: $380.86M High: $555.93M avg. 56.79% | Avg: $519.67M Low: $436.16M High: $636.65M avg. 14.52% |
FAQ
What is scPharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 117.46% in 2025-2028.
We have gathered data from 5 analysts. Their low estimate is -42.75M, average is -30.61M and high is -17.33M.
What is scPharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 191.56% in 2025-2028.
We have gathered data from 5 analysts. Their low revenue estimate is $74.76M, average is $95.72M and high is $119.76M.
What is scPharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 124.68% in 2025-2028.
We have gathered data from 5 analysts. Their low earnings per share estimate is -$1.11, average is -$0.73 and high is $-0.45.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering scPharmaceuticals stock. The most successful analyst is Glen Santangelo.